SCO-101 mediates resensitization of irinotecan (SN38) resistant colorectal cancer cells

被引：0
|
作者：
Stenvang, Jan
Roest, Nicklas Lindland
Vestlev, Peter Michael
Hansen, Bo Rode
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2021年 / 20卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-21-P077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P077
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An SN38 dendrimer nanoparticle, DEP irinotecan (SN38-SPL9111), demonstrates efficacy in mouse models of gastrointestinal cancer and augments anti-tumor effects of immune checkpoint blockade and PARP inhibition
    Blyth, Benjamin J.
    Kelly, Brian D.
    Giannis, Michael
    Cargill, Anne
    Seta, Aynaz
    Heery, Graham P.
    Eglezos, Anthony
    Johnstone, Cameron N.
    Paull, Jeremy R. A.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [42] In vitro cytotoxicity of chemoradiation with SN-38 in human colorectal cancer cells.
    Balcer-Kubiczek, E
    Wood, A
    Kennedy, AS
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3807S - 3807S
  • [43] Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
    Takigawa, Nagio
    Takeyama, Masami
    Kozuki, Toshiyuki
    Shibayama, Takuo
    Hisamoto, Akiko
    Kiura, Katsuyuki
    Tada, Atsuhiko
    Hotta, Katsuyuki
    Umemura, Shigeki
    Ohashi, Kadoaki
    Fujiwara, Yoshiro
    Takata, Saburo
    Ichihara, Eiki
    Osawa, Masahiro
    Tabata, Masahiro
    Tanimoto, Mitsune
    Takahashi, Kiyoshi
    ONCOLOGY REPORTS, 2007, 17 (05) : 983 - 987
  • [44] ABCC5 MODULATES SYSTEMIC EXPOSURE OF SN-38-GLUCORONIDE IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH IRINOTECAN
    Teft, Wendy A.
    Lenehan, John
    Welch, Stephen
    Kim, Richard B.
    DRUG METABOLISM REVIEWS, 2014, 45 : 31 - 31
  • [45] MicroRNAs related to intrinsic resistance to oxaliplatin and the irinotecan metabolite SN-38 in 10 colorectal cancer cell lines.
    Jensen, Niels Frank
    Soekilde, Rolf
    Stenvang, Jan
    Nielsen, Birgitte Sander
    Litman, Thomas
    Brunner, Nils
    Romer, Maria Unni
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [46] Fecal microbial SN-38G metabotypes in colorectal cancer patients are associated with irinotecan-induced delayed diarrhea
    Wu, Rongrong
    Chen, Junru
    Jia, Yifei
    Chen, Yijia
    Li, Yang
    Yan, Ru
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [47] Antiproliferative effects of ZD0473 (AMD473) in combination with 5-Fluorouracil or SN38 in human colorectal cancer cell lines
    Carmen Plasencia
    Albert Abad
    Eva Martinez-Balibrea
    Miquel Taron
    Investigational New Drugs, 2004, 22 : 399 - 409
  • [48] Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner
    Pathak, Surajit
    Meng, Wen-Jian
    Nandy, Suman Kumar
    Ping, Jie
    Bisgin, Atil
    Helmfors, Linda
    Waldmann, Patrik
    Sun, Xiao-Feng
    ONCOTARGET, 2015, 6 (42) : 44758 - 44780
  • [49] A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer
    Allen, Wendy L.
    Stevenson, Leanne
    Coyle, Vicky M.
    Jithesh, Puthen V.
    Proutski, Irina
    Carson, Gail
    Gordon, Michael A.
    Lenz, Heinz-Josef D.
    Van Schaeybroeck, Sandra
    Longley, Daniel B.
    Johnston, Patrick G.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (01) : 119 - 131
  • [50] Antiproliferative effects of ZD0473 (AMD473) in combination with 5-Fluorouracil or SN38 in human colorectal cancer cell lines
    Plasencia, C
    Abad, A
    Martinez-Balibrea, E
    Taron, M
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (04) : 399 - 409
12345